MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
🚨
Price Alert:
The stock price jumped by 12.35% after the earning call.
Cash Flow Overview
Change in Cash
$521,241K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Deferred income taxes
Proceeds from issuance of common...
Stock-based compensation
Others
Negative Cash Flow Breakdown
Sales and marketing
Research and development - inter...
Research and development - exter...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenues
1,674,039
1,272,676
1,506,835
1,365,980
Cost of sales (including definite-lived intangible amortization)
104,957
104,523
121,175
99,001
Contract dispute settlement
0
-
0
0
Research and development - internal
268,615
260,176
269,559
250,140
Research and development - external
248,335
243,127
272,389
256,344
Other research and development
0
12,600
69,424
100
Sales and marketing
285,752
259,563
308,489
272,302
General and administrative
65,983
68,524
81,923
56,779
Asset impairment
-
-
76,275
-
Asset impairment and related disposal costs
0
23,214
-
-
Loss on change in fair value of acquisition-related contingent consideration
2,499
-168
-28,258
-12,204
(profit) and loss sharing under collaboration agreements
-
-
0
0
Other segment items
112,293
-2,213
36,580
19,349
Net income
585,605
303,330
299,279
424,169
Depreciation and amortization
26,476
23,802
23,982
24,023
Stock-based compensation
67,263
64,126
62,157
61,598
Deferred income taxes
115,621
63,416
-13,497
-234,188
Other, net
-1,613
-12,772
-11,412
-6,665
(gain) loss on equity investments
9,805
6,591
18,246
8,558
Loss on change in fair value of acquisition-related contingent consideration
2,499
-168
-28,258
-12,204
Asset impairment
-
-
76,275
-
Accounts receivable
73,795
27,027
128,497
53,001
Prepaid expenses and other assets
14,042
-9,193
-65,038
72,835
Inventory
11,879
12,226
4,859
5,555
Accounts payable
22,431
23,449
32,976
-44,166
Accrued and other liabilities
-204,325
-84,725
138,545
115,136
Net cash provided by operating activities
507,662
369,351
543,301
559,389
Purchase of long term investments
40,000
-
7,875
-
Sale of equity investments
0
0
0
1
Capital expenditures
12,413
10,200
21,877
14,747
Payments for intangible assets
0
5,000
0
25,000
Purchases of marketable securities
31,380
142,703
82,655
115,506
Maturities of marketable securities
32,000
69,700
74,988
107,836
Net cash used in investing activities
-51,793
-88,203
-37,419
-47,416
Repurchase of common stock
-
-
0
0
Excise tax paid on repurchase of common stock
0
-
0
0
Proceeds from issuance of common stock under stock plans
75,148
97,925
160,209
43,430
Tax withholdings related to restricted and performance share vesting
3,932
6,956
16,349
50,103
Payment of finance lease liabilities
1,158
1,184
1,158
1,141
Payment of contingent consideration
4,602
4,963
4,963
15,298
Net cash provided by (used in) financing activities
65,456
84,822
137,739
-12,778
Effect of exchange rates on cash, cash equivalents, and restricted cash
-84
-2,689
-801
841
Net increase in cash, cash equivalents, and restricted cash
521,241
363,281
642,820
500,036
Cash, cash equivalents, and restricted cash at beginning of period
3,462,950
3,099,669
1,943,387
1,943,387
Cash, cash equivalents, and restricted cash at end of period
3,984,191
3,462,950
3,099,669
2,456,849
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Total revenues
$1,674,039K
(37.72%↑ Y/Y)
Net income
$585,605K
(44.59%↑ Y/Y)
Proceeds from issuance of
common stock under...
$75,148K
(404.89%↑ Y/Y)
Deferred income taxes
$115,621K
(199.01%↑ Y/Y)
Stock-based compensation
$67,263K
(4.11%↑ Y/Y)
Depreciation and
amortization
$26,476K
(15.52%↑ Y/Y)
Accounts payable
$22,431K
(12.66%↑ Y/Y)
Loss on change in fair
value of...
$2,499K
(-89.02%↓ Y/Y)
Other, net
-$1,613K
(-118.95%↓ Y/Y)
Canceled cashflow
$1,088,434K
Net cash provided by
operating activities
$507,662K
(1034.67%↑ Y/Y)
Net cash provided by
(used in) financing...
$65,456K
(682.04%↑ Y/Y)
Canceled cashflow
$313,846K
Canceled cashflow
$9,692K
Sales and marketing
$285,752K
(11.49%↑ Y/Y)
Research and development
- internal
$268,615K
(13.49%↑ Y/Y)
Research and development
- external
$248,335K
(1.08%↑ Y/Y)
Other segment items
$112,293K
(-10.39%↓ Y/Y)
Cost of sales
(including definite-lived...
$104,957K
(33.25%↑ Y/Y)
General and
administrative
$65,983K
(-11.68%↓ Y/Y)
Loss on change in fair
value of...
$2,499K
(-89.02%↓ Y/Y)
Net increase in
cash, cash...
$521,241K
(3782.33%↑ Y/Y)
Canceled cashflow
$51,877K
Accrued and other
liabilities
-$204,325K
(57.14%↑ Y/Y)
Accounts receivable
$73,795K
(264.80%↑ Y/Y)
Prepaid expenses and
other assets
$14,042K
(-83.75%↓ Y/Y)
Inventory
$11,879K
(-39.16%↓ Y/Y)
(gain) loss on equity
investments
$9,805K
(336.21%↑ Y/Y)
Payment of contingent
consideration
$4,602K
(-7.27%↓ Y/Y)
Tax withholdings
related to restricted...
$3,932K
(331.14%↑ Y/Y)
Payment of finance lease
liabilities
$1,158K
(0.26%↑ Y/Y)
Maturities of marketable
securities
$32,000K
(-43.17%↓ Y/Y)
Net cash used in
investing activities
-$51,793K
(-174.44%↓ Y/Y)
Effect of exchange
rates on cash, cash...
-$84K
(92.98%↑ Y/Y)
Canceled cashflow
$32,000K
Purchase of long term
investments
$40,000K
Purchases of marketable
securities
$31,380K
(-44.07%↓ Y/Y)
Capital expenditures
$12,413K
(-34.92%↓ Y/Y)
Buy us a coffee
Incyte_logo-svg
INCYTE CORP (INCY)
Incyte_logo-svg
INCYTE CORP (INCY)